Rosuvastatin Calcium Tablet
Product Images NDC 50090-7967

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 50090-7967). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907967)

Rosuvastatin Calcium 10 mg oral tablets carton label from A-S Medication Solutions, Libertyville, IL. The label includes dosage strength, NDC 50090-7967-0, storage instructions to keep at 68 to 77 degrees F, and package count of 30 tablets. It specifies Rosuvastatin Calcium as the active ingredient with USP equivalence.*

FDA Label Image

Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)

A line graph showing cumulative incidence percentage over years for Rosuvastatin Calcium (Rosuva) versus placebo. The graph includes a legend identifying the lines for Rosuva and placebo. The x-axis represents years from 0 to 6, and the y-axis shows cumulative incidence from 0% to 9%. Number at risk for RSV and placebo groups is shown below the graph. Statistical data with hazard ratio and p-value is displayed.*

FDA Label Image

Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)

A data table comparing the number of cardiovascular-related events between patients taking Rosuvastatin 20 mg and placebo. It presents endpoints including primary MCE, cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization, along with hazard ratios, confidence intervals, and p-values demonstrating statistical outcomes.*

FDA Label Image

Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)

Box plot chart comparing the percent change from baseline in LDL-C levels for four different statins (Crestor, Atorvastatin, Simvastatin, and Pravastatin) across various doses in milligrams (10 to 80). The y-axis shows percent change from 0 to -75, representing LDL-C reduction at different dose levels for each drug.*

FDA Label Image

Structural_formula (Rosuvastatin Tablets Structure)

Chemical structure diagram of rosuvastatin calcium, illustrating the molecular arrangement of the rosuvastatin calcium active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.